A detailed history of Elco Management Co., LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Elco Management Co., LLC holds 16,177 shares of KPTI stock, worth $13,588. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,177
Previous 19,662 17.72%
Holding current value
$13,588
Previous $17,000 23.53%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.06 $2,439 - $3,694
-3,485 Reduced 17.72%
16,177 $13,000
Q2 2024

Aug 14, 2024

SELL
$0.87 - $1.58 $10,647 - $19,337
-12,239 Reduced 38.37%
19,662 $17,000
Q1 2024

May 14, 2024

BUY
$0.72 - $1.66 $6,724 - $15,504
9,340 Added 41.4%
31,901 $48,000
Q4 2023

Feb 14, 2024

BUY
$0.68 - $1.31 $6,179 - $11,903
9,087 Added 67.44%
22,561 $19,000
Q2 2023

Aug 11, 2023

BUY
$1.79 - $4.59 $24,118 - $61,845
13,474 New
13,474 $24,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Elco Management Co., LLC Portfolio

Follow Elco Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elco Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elco Management Co., LLC with notifications on news.